PATENT CLAIM ANALYSIS

Application Number: 16011167
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["435", "006120"]

Abstract:
Differential expression of long non-coding RNAs (lncRNAs) and enhancer RNAs (eRNAs) are used to diagnose diseases including neurological diseases, inflammatory diseases, rheumatic diseases, and autoimmune diseases. Machine learning systems are used to identify lncRNAs or eRNAs having differential expression correlated with certain disease states.

Claim (Index 2):
The method of  claim 1 , wherein the disease is selected from the group consisting of a neurological disease, an inflammatory disease, a rheumatic disease, and an autoimmune disease.

Metadata:
- Claim Count in Document: 57.0
- Percentile: 94.0
- Lexical Diversity: 1.47222
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15557214', '15126927', '14020811', '13789546', '15171883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6317281390607598
- 35 USC 102 Novelty (BERT): 0.5153126319539583
- Combined Prediction Score: 0.6200865883500796
- Mean Citation Score: 242.861454
- Max Citation Score: 289.99106
- Similarity Product: 172.42227794311765

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test